Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
Details for Australian Patent Application No. 2007202942 (hide)
International Classifications
Event Publications
12 July 2007 Complete Application Filed
19 July 2007 Application Open to Public Inspection
Published as AU-B-2007202942
7 May 2009 Assignment before Grant
Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc.
5 November 2009 Alteration of Name
The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.
27 May 2010 Application Accepted
Published as AU-B-2007202942
23 September 2010 Standard Patent Sealed
16 December 2010 Assignment Registered
Novartis Vaccines and Diagnostics, Inc. The patent has been assigned to Novartis AG
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007202943-Polymorph of a pharmaceutical
2007202941-Nanoparticulate and controlled release compositions comprising cephalosporin
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser